Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitealvinepharma.com
CategoryBioTech
Phone(650) 632-1645
Emailinfo@alvinepharma...
Employees
Founded2005
Descriptionbiopharmaceutical company

Offices

HQ
75 Shoreway Rd.
Suite B
San Carlos, CA, 94070
USA

People

President and CEO
Vice President of Quality and Regulatory Affairs
Vice President of Marketing and Corporate & Strategic Development
Board Member
Board of Directors
Director
Director
Director
Show All People

Funding

TOTAL $126M
FUNDING TOTAL $126M
Series A, 9/2006
Prospect Venture Partners
Sofinnova Ventures
$8M
Series A, 9/2009
Panorama Capital
InterWest Partners
Prospect Venture Partners
Sofinnova Ventures
Black River Asset Management
Flagship Ventures
$21.5M
Venture Round, 3/2011
$26.5M
Private Equity, 5/2013
AbbVie
$70M
DEBT TOTAL $12M
Debt, 10/2011
$6.01M
Debt, 1/2013
$6.01M

Tags

Alvine Pharmaceuticals

Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine’s lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.

Recent Milestones

Videos

Screenshots

Sources

  1. Alvine Pharma raises nearly $8M from Prospect, Sofinnova (venturebeat.com) [edit]
  2. Alvine gobbles $21.5M to treat gastrointestinal disease (venturebeat.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. Alvine lands $70 million from AbbVie for celiac disease drug (bizjournals.com) [edit]
Edit This Page
Last Edited 12/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy